These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 36637349)
21. An unusual loss of EGFR gene copy in glioblastoma multiforme in a child: a case report and analysis of a successfully derived HGG-02 cell line. Veselska R; Skoda J; Loja T; Zitterbart K; Pavelka Z; Smardova J; Valaskova I; Hermanova M; Sterba J Childs Nerv Syst; 2010 Jun; 26(6):841-6. PubMed ID: 20195615 [TBL] [Abstract][Full Text] [Related]
23. Studying a complex tumor: potential and pitfalls. Zheng S; Chheda MG; Verhaak RG Cancer J; 2012; 18(1):107-14. PubMed ID: 22290264 [TBL] [Abstract][Full Text] [Related]
24. Gene therapy for glioblastoma: future perspective for delivery systems and molecular targets. Shir A; Levitzki A Cell Mol Neurobiol; 2001 Dec; 21(6):645-56. PubMed ID: 12043839 [No Abstract] [Full Text] [Related]
25. Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy. Ji H; Ba Y; Ma S; Hou K; Mi S; Gao X; Jin J; Gong Q; Liu T; Wang F; Liu Z; Li S; Du J; Hu S Front Immunol; 2021; 12():729359. PubMed ID: 34566988 [TBL] [Abstract][Full Text] [Related]
26. Aurora kinase A as a rational target for therapy in glioblastoma. Barton VN; Foreman NK; Donson AM; Birks DK; Handler MH; Vibhakar R J Neurosurg Pediatr; 2010 Jul; 6(1):98-105. PubMed ID: 20593995 [TBL] [Abstract][Full Text] [Related]
28. Effect of Notch expression in glioma stem cells on therapeutic response to chemo-radiotherapy in recurrent glioblastoma. Saito N; Aoki K; Hirai N; Fujita S; Iwama J; Hiramoto Y; Ishii M; Sato K; Nakayama H; Harashina J; Hayashi M; Izukura H; Kimura H; Ito K; Sakurai T; Yokouchi Y; Oharazeki T; Takahashi K; Iwabuchi S Brain Tumor Pathol; 2015 Jul; 32(3):176-83. PubMed ID: 25665548 [TBL] [Abstract][Full Text] [Related]
29. Taming a mutinous mutant: an errant receptor becomes a prime cancer target. Goldman B J Natl Cancer Inst; 2007 Apr; 99(7):504-5. PubMed ID: 17405993 [No Abstract] [Full Text] [Related]
35. The emerging role of MMP14 in brain tumorigenesis and future therapeutics. Ulasov I; Yi R; Guo D; Sarvaiya P; Cobbs C Biochim Biophys Acta; 2014 Aug; 1846(1):113-20. PubMed ID: 24657728 [TBL] [Abstract][Full Text] [Related]
36. Viral therapy for glioblastoma. Chiocca EA; Aghi M; Fulci G Cancer J; 2003; 9(3):167-79. PubMed ID: 12952302 [TBL] [Abstract][Full Text] [Related]
37. Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome. Cesarini V; Martini M; Vitiani LR; Gravina GL; Di Agostino S; Graziani G; D'Alessandris QG; Pallini R; Larocca LM; Rossi P; Jannini EA; Dolci S Oncotarget; 2017 Feb; 8(8):13223-13239. PubMed ID: 28099939 [TBL] [Abstract][Full Text] [Related]
38. Glioblastoma in a patient with a hereditary cancer syndrome. Steckley JL; Watling CJ; Ng W Can J Neurol Sci; 2008 Mar; 35(1):98-101. PubMed ID: 18380286 [No Abstract] [Full Text] [Related]
39. Nanoparticle engineered TRAIL-overexpressing adipose-derived stem cells target and eradicate glioblastoma via intracranial delivery. Jiang X; Fitch S; Wang C; Wilson C; Li J; Grant GA; Yang F Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13857-13862. PubMed ID: 27849590 [TBL] [Abstract][Full Text] [Related]